Remove Doctors Remove Food and Drug Administration Remove Leads Remove Recruitment
article thumbnail

Healthcare Watch July/August 2022

PM360

Doctor Docs: Oncologists React to ASCO Educational Material. Another 17% recommended mandating patient recruitment requirements and 14% would like to see the development of a diverse pool of investigators and staff. EPA Administrator Michael Regan said the agency will take more aggressive action against PFAS. Drug Approvals.

article thumbnail

Digital clinical trials: Trends to watch in 2023

Pharmaceutical Technology

Metabolic disorders have remained the leading therapy area for DCT adoption for over five years, mainly due to the use of wearables, such as glucometers, and other smart devices. In the US, the FDA (Food and Drug Administration) granted accelerated approvals of medical devices with AI in 2022 [8] , and growing use is expected throughout 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The NIH on accelerating research using diverse biomedical datasets

pharmaphorum

. “What we’re really trying to do is drive discoveries that can lead to more tailored prevention, diagnosis, and treatment for all individuals. This dual approach will lead to better medical research that will benefit all populations.” In March 2020, when the pandemic hit, we had to pause in-person recruitment.

article thumbnail

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

Impetus Digital

We know from real-world evidence that drug efficacy and safety can differ based on age, sex, race, and ethnicity; these discrepancies may jeopardize treatment outcomes in undertested groups. Many clinical trials are struggling to recruit diverse participants, particularly from rural or remote areas far from large academic hospitals.

Pharma 90
article thumbnail

CardieX Receives FDA 510(K) Clearance for a World-First Vascular Biometric Monitor – the CONNEQT Pulse

Legacy MEDSearch

Food and Drug Administration (FDA). The FDA’s clearance of the Pulse democratizes CardieX’s market leading SphygmoCor technology by bringing deep vascular insights and clinically relevant heart health metrics to market at a price point that is now affordable to all.

FDA 52
article thumbnail

Uri Goren

Cadensee

It's become the main thing that the doctors are looking at now. And did you know at the time that you were a trailblazer in this space? It broke the confines of you being a doctor learning healthcare, learning to be a medical profession and that stayed there; it just broke it all. They can help you recruit through those communities.

article thumbnail

Virtual clinical trials: How digital tech has improved clinical trial accrual rates

Pharmaceutical Technology

Other processes include direct-to-patient (DtP) shipments of drugs and other supplies to a patient’s home, as well as in-home care with mobile nurses. Recent GlobalData research [ii] has shown that, over the past 10 years, fewer trials are being terminated due to low recruitment.